cepharanthine has been researched along with rhodamine 123 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goi, K; Ichihara, T; Koizumi, S; Konishi, M; Matsukawa, H; Mizutani, S; Wada, H | 1 |
| Cai-Hong, Z; Fang, M; Jin-Hua, J; Li, H; Ning, W; Qing-Duan, W; Xiao-Juan, G; Yan, Z | 1 |
| Han, L; Jiang, JH; Peng, YM; Wang, N; Wang, QD; Wang, YF; Zhang, Y; Zhou, YB | 1 |
3 other study(ies) available for cepharanthine and rhodamine 123
| Article | Year |
|---|---|
Flow cytometric functional analysis of multidrug resistance by Fluo-3: a comparison with rhodamine-123.
Topics: Alkaloids; Aniline Compounds; ATP Binding Cassette Transporter, Subfamily B, Member 1; Base Sequence; Benzylisoquinolines; Calcium Channel Blockers; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Fluorescent Dyes; Gene Expression; Humans; Molecular Sequence Data; Polymerase Chain Reaction; Rhodamine 123; Rhodamines; Tumor Cells, Cultured; Verapamil; Xanthenes | 1995 |
Using rhodamine 123 accumulation in CD8 cells as a surrogate indicator to study the P-glycoprotein modulating effect of cepharanthine hydrochloride in vivo.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzylisoquinolines; Carcinoma, Hepatocellular; CD8-Positive T-Lymphocytes; Cyclosporine; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Fluorescent Dyes; Fluorouracil; Humans; Indicators and Reagents; Liver Neoplasms; Mice; Rhodamine 123; Tumor Cells, Cultured; Verapamil; Xenograft Model Antitumor Assays | 2011 |
[Correlation between reversing effect of cepharanthine hydrochloride on multidrug resistance and P-glycoprotein expression and function of K562/ADR cells].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzylisoquinolines; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; K562 Cells; Rhodamine 123 | 2012 |